Journal article
Overexpression of CD39 protects in a mouse model of preeclampsia
JL McRae, PA Russell, JSJ Chia, KM Dwyer
Nephrology | Published : 2013
DOI: 10.1111/nep.12058
Abstract
CD39 (NTPDase1), a critical immune and vascular ecto-nucleotidase, hydrolyses pro-inflammatory and pro-thrombotic nucleotides (adenosine-5′- triphosphate (ATP) and adenosine diphosphate) to adenosine. In humans, CD39 is the dominant ecto-nucleotidase in placental trophoblastic tissues and modulates ATP-dependent trophoblastic functions. CD39 is an integral component of regulatory T cells (Treg), which are central to immunological tolerance and maintenance of normal pregnancy. We examined the impact of CD39 overexpression in a mouse model of preeclampsia. Matings were performed between virginal BALB/c female (wild-type (WT) or CD39 transgenic (CD39TG)) and C57BL/6 male mice. On days 10 and 12..
View full abstractGrants
Funding Acknowledgements
KM Dwyer acknowledges support from the Royal Australasian College of Physicians, Jacquot Establishment Award and the Sylvia and Charles Viertel Charitable Foundation, Australia. We thank Bioresources Centre staff for animal maintenance.